Lim Bryant David 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Jul 12, 2021
Insider Transaction Report
Form 4
Lim Bryant David
SVP & General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2021-07-08+66,500→ 66,500 totalExercise: $1.11Exp: 2031-07-08→ Common Stock (66,500 underlying)
Footnotes (1)
- [F1]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on July 8, 2021. Twenty-five percent (25%) of the stock option vests and becomes exercisable on July 8, 2022 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.